Regenxbio Research Development from 2010 to 2026

RGNX Stock  USD 14.59  0.41  2.73%   
Regenxbio Research Development yearly trend continues to be fairly stable with very little volatility. Research Development will likely drop to about 125.5 M in 2026. During the period from 2010 to 2026, Regenxbio Research Development regression line of annual values had r-squared of  0.80 and arithmetic mean of  102,910,261. View All Fundamentals
 
Research Development  
First Reported
2013-12-31
Previous Quarter
55.6 M
Current Value
56.1 M
Quarterly Volatility
21.2 M
 
Yuan Drop
 
Covid
Check Regenxbio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Regenxbio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 19.6 M, Interest Expense of 16.3 M or Selling General Administrative of 50.8 M, as well as many indicators such as Price To Sales Ratio of 5.02, Dividend Yield of 0.0 or PTB Ratio of 1.39. Regenxbio financial statements analysis is a perfect complement when working with Regenxbio Valuation or Volatility modules.
  
Build AI portfolio with Regenxbio Stock
Check out the analysis of Regenxbio Correlation against competitors.
For more information on how to buy Regenxbio Stock please use our How to Invest in Regenxbio guide.

Latest Regenxbio's Research Development Growth Pattern

Below is the plot of the Research Development of Regenxbio over the last few years. It is Regenxbio's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Regenxbio's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

Regenxbio Research Development Regression Statistics

Arithmetic Mean102,910,261
Geometric Mean45,631,787
Coefficient Of Variation90.32
Mean Deviation82,019,924
Median83,873,000
Standard Deviation92,946,411
Sample Variance8639T
Range237.5M
R-Value0.89
Mean Square Error1847.7T
R-Squared0.80
Slope16,457,643
Total Sum of Squares138224.6T

Regenxbio Research Development History

2026125.5 M
2025239.8 M
2024208.5 M
2023232.3 M
2022242.5 M
2021181.4 M
2020166.3 M

About Regenxbio Financial Statements

Regenxbio investors use historical fundamental indicators, such as Regenxbio's Research Development, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Regenxbio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Research Development239.8 M125.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Regenxbio Stock Analysis

When running Regenxbio's price analysis, check to measure Regenxbio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regenxbio is operating at the current time. Most of Regenxbio's value examination focuses on studying past and present price action to predict the probability of Regenxbio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regenxbio's price. Additionally, you may evaluate how the addition of Regenxbio to your portfolios can decrease your overall portfolio volatility.